This is a Validated Antibody Database (VAD) review about human IL7R, based on 132 published articles (read how Labome selects the articles), using IL7R antibody in all methods. It is aimed to help Labome visitors find the most suited IL7R antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IL7R synonym: CD127; CDW127; IL-7R-alpha; IL7RA; ILRA

BioLegend
mouse monoclonal (A019D5)
  • mass cytometry; human; loading ...; fig s4a
BioLegend IL7R antibody (Biolegend, 351337) was used in mass cytometry on human samples (fig s4a). Biomark Res (2022) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; 1:100; loading ...; fig s7a
BioLegend IL7R antibody (Biolegend, A019D5) was used in flow cytometry on human samples at 1:100 (fig s7a). Nat Commun (2021) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 3b
BioLegend IL7R antibody (Biolegend, A019D5) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig s1-1
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig s1-1). elife (2020) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...
BioLegend IL7R antibody (BioLegend, 351327) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; mouse; loading ...
BioLegend IL7R antibody (BioLegend, 351310) was used in flow cytometry on mouse samples . Cell (2020) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 2a
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 2a). JCI Insight (2020) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...
BioLegend IL7R antibody (BioLegend, 351304) was used in flow cytometry on human samples . Nature (2020) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; fig 7b
BioLegend IL7R antibody (Biolegend, 351320) was used in flow cytometry on human samples (fig 7b). Cell Rep (2019) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig s20
BioLegend IL7R antibody (Biolegend, 351329) was used in flow cytometry on human samples (fig s20). Science (2019) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 1a
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2019) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig s7b
BioLegend IL7R antibody (Biolegend, 351310) was used in flow cytometry on human samples (fig s7b). Nat Commun (2019) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig s3d
BioLegend IL7R antibody (Biolegend, 351302) was used in flow cytometry on human samples (fig s3d). Cell (2019) ncbi
mouse monoclonal (A019D5)
  • other; human; loading ...; fig 4b
BioLegend IL7R antibody (BioLegend, 351352) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 1a
BioLegend IL7R antibody (BioLegend, 351310) was used in flow cytometry on human samples (fig 1a). Sci Rep (2019) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; 1:33; loading ...; fig 6g
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples at 1:33 (fig 6g). Gastroenterology (2019) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; tbl s1
BioLegend IL7R antibody (Biolegend, A019D5) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 5b
BioLegend IL7R antibody (Biolegend, 351309) was used in flow cytometry on human samples (fig 5b). Nat Immunol (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 1a
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 1a). Bone Marrow Transplant (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend IL7R antibody (Biolegend, A019D5) was used in flow cytometry on mouse samples (fig 4f). J Exp Med (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 3a
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 3a). J Exp Med (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 5a
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 5a). J Exp Med (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 7a
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 7a). Nat Immunol (2018) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human
In order to investigate the role of dopamine in B cell maturation in germinal centres, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 2b
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 2b). Sci Rep (2017) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig s3c
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig s3c). J Clin Invest (2017) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend IL7R antibody (BioLegend, 351310) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; mouse; 1:200; fig 8f
In order to find that armadillo repeat containing 5 is crucial in fetal development, T-cell function and adrenal gland growth homeostasis, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on mouse samples at 1:200 (fig 8f). Nat Commun (2017) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 2e
In order to observe that the use of chimeric antigen receptor technology is a clinically applicable refinement of regulatory T cell therapy for organ transplantation, BioLegend IL7R antibody (Biolegend, A019D5) was used in flow cytometry on human samples (fig 2e). Am J Transplant (2017) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 7b
In order to determine which cells express CD83, BioLegend IL7R antibody (BioLegend, AO19D5) was used in flow cytometry on human samples (fig 7b). J Immunol (2016) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; fig 7
BioLegend IL7R antibody (Biolegend, 351317) was used in flow cytometry on human samples (fig 7). PLoS ONE (2016) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...
In order to assess how ABCG1 loss in T cells affects atherosclerosis, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples . J Clin Invest (2016) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig s2
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig s2). Am J Transplant (2016) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend IL7R antibody (biolegend, A019D5) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 8a
BioLegend IL7R antibody (Biolegend, 8019D5) was used in flow cytometry on human samples (fig 8a). PLoS Pathog (2016) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 4c
In order to discuss the importance of IL-5 positive Th2 cells to allergies, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 4c). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; fig s4
In order to assess arming of MAIT cell cytolytic antimicrobial activity and induction by IL-7 and faulty in HIV-1 infection, BioLegend IL7R antibody (Biolegend, A019D5) was used in flow cytometry on human samples (fig s4). PLoS Pathog (2015) ncbi
mouse monoclonal (A019D5)
  • immunohistochemistry; human; 1:20; fig 4
BioLegend IL7R antibody (Biolegend, 351312) was used in immunohistochemistry on human samples at 1:20 (fig 4). Reproduction (2015) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; fig 6
In order to report the phase I trial results of CDX-301, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 6). Bone Marrow Transplant (2015) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human
BioLegend IL7R antibody (Biolegend, 351310) was used in flow cytometry on human samples . Scand J Immunol (2015) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; fig 1
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human
BioLegend IL7R antibody (Biolegend, 351324) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human
BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human; loading ...; fig 2f
In order to discuss the therapeutic use of ex vivo-generated Akt-inhibited minor histocompatibility antigen-specific CD8+ T cells, BioLegend IL7R antibody (BioLegend, A019D5) was used in flow cytometry on human samples (fig 2f). Blood (2014) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend IL7R antibody (Biolegend, A019D5) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (A019D5)
  • flow cytometry; human
BioLegend IL7R antibody (Biolegend, clone A019D5) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
Invitrogen
mouse monoclonal (eBioRDR5)
  • flow cytometry; mouse; 1:1000; loading ...
Invitrogen IL7R antibody (Thermo Fisher Scientific, 12-1278-42) was used in flow cytometry on mouse samples at 1:1000. Cell Rep Med (2021) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 1
Invitrogen IL7R antibody (E-Biosience, eBioRDR5) was used in flow cytometry on human samples (fig 1). Arthritis Res Ther (2021) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples (fig 1a). Eur J Immunol (2019) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 5a
Invitrogen IL7R antibody (eBiosciences, eBioRDR5) was used in flow cytometry on human samples (fig 5a). Front Immunol (2018) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 1
Invitrogen IL7R antibody (ThermoFisher Scientific, eBioRDR5) was used in flow cytometry on human samples (fig 1). Am J Transplant (2019) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen IL7R antibody (Thermo Fisher, 12-1278-41) was used in flow cytometry on human samples (fig 2a). Cell Rep (2018) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; rhesus macaque; loading ...; fig 2f
Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on rhesus macaque samples (fig 2f). J Virol (2019) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; fig s5c
Invitrogen IL7R antibody (eBioscience, 25-1278-41) was used in flow cytometry on human samples (fig s5c). Genes Dev (2018) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 4b
Invitrogen IL7R antibody (Life Technologies, eBIORDR5) was used in flow cytometry on human samples (fig 4b). AIDS (2018) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 1
Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples (fig 1). Am J Trop Med Hyg (2018) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen IL7R antibody (eBiosciences, eBioRDR5) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2017) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 7
Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples (fig 7). J Virol (2018) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human
In order to investigate the role of dopamine in B cell maturation in germinal centres, Invitrogen IL7R antibody (eBioscience, 11-1278) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 3d
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen IL7R antibody (Thermo Fischer Scientific, 17-1278) was used in flow cytometry on human samples (fig 3d). Cell Res (2017) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; fig s2a
In order to characterize fetal natural killer cells, Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples (fig s2a). JCI Insight (2017) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 5a
Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples (fig 5a). Blood (2017) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; 1:25; loading ...; fig 1b
In order to explore the role of thrombopoietin signaling in the human primitive hematopoietic stem cell compartment, Invitrogen IL7R antibody (eBiosciences, eBioRDR5) was used in flow cytometry on human samples at 1:25 (fig 1b). Cell Transplant (2017) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; rhesus macaque; loading ...; fig 2
In order to assess the efficacy of targeting alpha4 beta7 integrin to treat SIV, Invitrogen IL7R antibody (eBiosciences, 25-1278-42) was used in flow cytometry on rhesus macaque samples (fig 2). Science (2016) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 3a
In order to investigate the basis for T regulatory cell accumulation in melanoma, Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples (fig 3a). Cancer Res (2016) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; fig 8
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, Invitrogen IL7R antibody (eBioscience, 45-1278-42) was used in flow cytometry on human samples (fig 8). Nat Immunol (2016) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; 1:20; fig st2
Invitrogen IL7R antibody (eBioscience, 45-1278-42) was used in flow cytometry on human samples at 1:20 (fig st2). Nat Commun (2016) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; 1:100; tbl 2
Invitrogen IL7R antibody (eBioscience, 25-1278-42) was used in flow cytometry on human samples at 1:100 (tbl 2). Oncoimmunology (2016) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; fig 4
In order to develop an HLA-A2-specific chimeric antigen receptor and use it to generate alloantigen-specific human T regulatory cells, Invitrogen IL7R antibody (eBiosciences, 48-1278-42) was used in flow cytometry on human samples (fig 4). J Clin Invest (2016) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; fig st1
Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples (fig st1). J Autoimmun (2016) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; marmosets; loading ...; fig 1a
In order to test a therapeutic antibody against CD127 in a mouse model of experimental autoimmune encephalomyelitis, Invitrogen IL7R antibody (Ebiosciences, ebioDR5) was used in flow cytometry on marmosets samples (fig 1a). J Neuroimmune Pharmacol (2016) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; rhesus macaque; loading ...; fig 1a
In order to use lymph node fine-needle aspiration to examine the dynamics of T-follicular helper cells during SIV infection, Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on rhesus macaque samples (fig 1a). J Med Primatol (2015) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...
In order to develop feasible methods to generate cytomegalovirus-specific T cells from naive cells for T cell therapy, Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples . Sci Transl Med (2015) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; fig 1
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen IL7R antibody (eBioscience, eBioRDRS) was used in flow cytometry on human samples (fig 1). Cancer Immunol Res (2015) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; fig 7
Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples (fig 7). Nat Commun (2015) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human
Invitrogen IL7R antibody (ebioscience, eBioRDR5) was used in flow cytometry on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human
Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human
In order to examine the role of TLR7 in HIV-infected CD4 positive T cells, Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples . Nat Immunol (2015) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human
Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human
Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human
Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 4b
In order to test if proteasome-inhibition complements the effects of corticosteroids to improve outcomes in chronic graft-versus-host disease, Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples (fig 4b). Biol Blood Marrow Transplant (2014) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; tbl 1
In order to study the effect of innate lymphoid cells on B cells, Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples (tbl 1). Nat Immunol (2014) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human
In order to examine human differentiated effector CD4(+) T cells that are defined by low levels of IL-2 and IL-7 receptors, Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
mouse monoclonal (eBioRDR5)
  • immunocytochemistry; human
Invitrogen IL7R antibody (eBiosciences, eBioRDR5) was used in immunocytochemistry on human samples . J Cell Physiol (2014) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human
Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples . J Hepatol (2014) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 3b
In order to perform a phase I study in subjects with steroid-refractory chronic graft-versus-host disease using an anti-CD52 antibody, Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples (fig 3b). Biol Blood Marrow Transplant (2013) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...
In order to test if bortezomib inhibits graft-versus-host disease after T-cell-replete HLA-mismatched transplantation, Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples . J Clin Oncol (2012) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human; loading ...; fig 1e
In order to test if low-dose interleukin-2 enhances T regulatory cells and suppresses chronic graft-versus-host disease, Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples (fig 1e). N Engl J Med (2011) ncbi
mouse monoclonal (eBioRDR5)
  • flow cytometry; human
In order to determine the role for DOCK8 in peripheral CD8 T cell survival and function, Invitrogen IL7R antibody (eBioscience, eBioRDR5) was used in flow cytometry on human samples . J Exp Med (2011) ncbi
Miltenyi Biotec
mouse monoclonal (MB15-18C9)
  • flow cytometry; human; loading ...; fig 1b
Miltenyi Biotec IL7R antibody (Miltenyi Biotec, MB15-18C9) was used in flow cytometry on human samples (fig 1b). FEBS Lett (2017) ncbi
Beckman Coulter
mouse monoclonal (R34.34)
  • flow cytometry; human; loading ...; fig s1
Beckman Coulter IL7R antibody (Beckman Coulter, R34.34) was used in flow cytometry on human samples (fig s1). EBioMedicine (2020) ncbi
mouse monoclonal (R34.34)
  • flow cytometry; human; loading ...; fig s8a
Beckman Coulter IL7R antibody (Beckman Coulter, R34.34) was used in flow cytometry on human samples (fig s8a). Nat Commun (2020) ncbi
mouse monoclonal (R34.34)
  • flow cytometry; human; loading ...; fig ex1
Beckman Coulter IL7R antibody (Beckman Coulter, R34.34) was used in flow cytometry on human samples (fig ex1). Nature (2019) ncbi
mouse monoclonal (R34.34)
  • flow cytometry; human; 1:10; loading ...; fig 2a
Beckman Coulter IL7R antibody (Beckman Coulter, A71116) was used in flow cytometry on human samples at 1:10 (fig 2a). Nat Med (2019) ncbi
mouse monoclonal (R34.34)
  • flow cytometry; human; fig 1a
Beckman Coulter IL7R antibody (Beckman Coulter, R34.34) was used in flow cytometry on human samples (fig 1a). J Allergy Clin Immunol (2018) ncbi
mouse monoclonal (R34.34)
  • flow cytometry; human; loading ...; fig 4a
In order to report that patients with PTEN mutations experience autoimmunity and lymphoid hyperplasia, Beckman Coulter IL7R antibody (Immunotec, R34.34) was used in flow cytometry on human samples (fig 4a). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (R34.34)
  • flow cytometry; human; fig 1a
In order to analyze HIV progression traits of a selective loss of early differentiated and highly functional PD1high CD4 T cells, Beckman Coulter IL7R antibody (Beckman Coulter, R34.34) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2015) ncbi
mouse monoclonal (R34.34)
  • flow cytometry; human
Beckman Coulter IL7R antibody (Beckman Coulter, Clone R34.34) was used in flow cytometry on human samples . Int J Infect Dis (2015) ncbi
mouse monoclonal (R34.34)
  • flow cytometry; human; fig s1
Beckman Coulter IL7R antibody (Beckman Coulter, R34.34) was used in flow cytometry on human samples (fig s1). J Immunol (2015) ncbi
mouse monoclonal (R34.34)
  • flow cytometry; human; fig 6
Beckman Coulter IL7R antibody (beckman Coulter, R34.34) was used in flow cytometry on human samples (fig 6). Stem Cell Res Ther (2015) ncbi
mouse monoclonal (R34.34)
  • flow cytometry; human
Beckman Coulter IL7R antibody (Beckman-Coulter, R34.34) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (R34.34)
  • flow cytometry; human
Beckman Coulter IL7R antibody (Beckman Coulter, A71116) was used in flow cytometry on human samples . Ann Neurol (2014) ncbi
mouse monoclonal (R34.34)
  • flow cytometry; human
In order to examine human differentiated effector CD4(+) T cells that are defined by low levels of IL-2 and IL-7 receptors, Beckman Coulter IL7R antibody (Beckman, R34.34) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
BD Biosciences
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; fig 8d
BD Biosciences IL7R antibody (BD Biosciences, hIL-7R-M21) was used in flow cytometry on human samples (fig 8d). J Clin Invest (2022) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; 1:50; loading ...; fig s4d
BD Biosciences IL7R antibody (BD Biosciences, HIL-7R-M21) was used in flow cytometry on human samples at 1:50 (fig s4d). Nature (2021) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; fig s2
BD Biosciences IL7R antibody (BD Bioscience, HIL-7R-M21) was used in flow cytometry on human samples (fig s2). J Immunother Cancer (2021) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...
BD Biosciences IL7R antibody (BD, 560822) was used in flow cytometry on human samples . Cell (2021) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; fig st2
BD Biosciences IL7R antibody (Becton Dickinson, HIL-7R-M21) was used in flow cytometry on human samples (fig st2). EBioMedicine (2020) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences IL7R antibody (Becton Dickinson, HIL-7R-M21) was used in flow cytometry on human samples (fig 4a). Arthritis Res Ther (2020) ncbi
monoclonal (HIL-7R-M21)
  • flow cytometry; human; 1:250; loading ...
BD Biosciences IL7R antibody (BD Biosciences, 742547) was used in flow cytometry on human samples at 1:250. Nature (2020) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; 1:50; loading ...; fig 1a
BD Biosciences IL7R antibody (BD Biosciences, HIL-7R-M21) was used in flow cytometry on human samples at 1:50 (fig 1a). Nat Commun (2019) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences IL7R antibody (BD, HIL-7R-M21) was used in flow cytometry on human samples (fig 2d). PLoS Pathog (2019) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; fig 3f, 3g
BD Biosciences IL7R antibody (BD Biosciences, HIL-7R-M21) was used in flow cytometry on human samples (fig 3f, 3g). Brain Pathol (2020) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences IL7R antibody (BD Biosciences, HIL-7R-M21) was used in flow cytometry on human samples (fig 2a). Cancer (2019) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; tbl 1
BD Biosciences IL7R antibody (BD Biosciences, 557938) was used in flow cytometry on human samples (tbl 1). J Clin Invest (2018) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences IL7R antibody (BD Biosciences, HIL-7R-M21) was used in flow cytometry on human samples (fig 1c). Sci Rep (2017) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; fig 1d
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, BD Biosciences IL7R antibody (BD Pharmingen, HIL-7R-M21) was used in flow cytometry on human samples (fig 1d). J Clin Invest (2017) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences IL7R antibody (BD Biosciences, 560549) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2017) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; fig S1b
BD Biosciences IL7R antibody (BD, 560549) was used in flow cytometry on human samples (fig S1b). Sci Rep (2017) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences IL7R antibody (BD Pharmingen, HIL-7R-M21) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; fig s2
BD Biosciences IL7R antibody (BD, HIL-7R-M21) was used in flow cytometry on human samples (fig s2). PLoS Pathog (2016) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; fig 2b
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, BD Biosciences IL7R antibody (BD Biosciences, HIL-7R-M21) was used in flow cytometry on human samples (fig 2b). J Clin Invest (2016) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; fig s2
In order to study activation of myeloid dendritic cells, regulatory T cells and effector cells in lichen planus, BD Biosciences IL7R antibody (BD Biosciences, HIL-7R-M21) was used in flow cytometry on human samples (fig s2). J Transl Med (2016) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; fig s1
In order to find predictive markers for patients that will develop gastrointestinal graft-versus-host-disease, BD Biosciences IL7R antibody (BD Biosciences, HIL-7R-M21) was used in flow cytometry on human samples (fig s1). JCI Insight (2016) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences IL7R antibody (BD, 557938) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; fig 7
BD Biosciences IL7R antibody (BD PharMingen, 560551) was used in flow cytometry on human samples (fig 7). Immunity (2016) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; fig st1
BD Biosciences IL7R antibody (BD Pharmingen, HIL-7R-M21) was used in flow cytometry on human samples (fig st1). J Autoimmun (2016) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; 1:50; tbl 1
BD Biosciences IL7R antibody (BD Pharmingen, 557938) was used in flow cytometry on human samples at 1:50 (tbl 1). PLoS ONE (2015) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; fig 1
BD Biosciences IL7R antibody (BD Biosciences, 560822) was used in flow cytometry on human samples (fig 1). Retrovirology (2015) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; fig 8
BD Biosciences IL7R antibody (BD Biosciences, HIL7-R M21) was used in flow cytometry on human samples (fig 8). J Clin Invest (2015) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human
In order to determine the proportions, phenotype, survival, and apoptotic susceptibility of Tregs in sarcoidosis, BD Biosciences IL7R antibody (BD biosciences, hIL7R-M21) was used in flow cytometry on human samples . Respir Res (2015) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; fig 2
In order to elucidate Th17 cell polarization, depletion, and restoration in response to HIV infection and antiretroviral therapy, BD Biosciences IL7R antibody (BD Pharmingen, HIL-7R-M21) was used in flow cytometry on human samples (fig 2). Retrovirology (2015) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human
BD Biosciences IL7R antibody (BD Biosciences, hIL-7R-M21) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; tbl s2
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, BD Biosciences IL7R antibody (BD Biosciences, HIL-7R-M21) was used in flow cytometry on human samples (tbl s2). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; fig 1
BD Biosciences IL7R antibody (BD Biosciences, hIL-7R-M21) was used in flow cytometry on human samples (fig 1). J Autoimmun (2015) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human
BD Biosciences IL7R antibody (BD, HIL-7R-M21) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human
BD Biosciences IL7R antibody (BD, M21) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (HIL-7R-M21)
  • flow cytometry; human; loading ...; fig 3b
In order to show that latency-associated peptide and glycoprotein A repetitions predominant identify human antigen-specific T regulatory cells, BD Biosciences IL7R antibody (BD, hIL-7R-M21) was used in flow cytometry on human samples (fig 3b). Eur J Immunol (2014) ncbi
Articles Reviewed
  1. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed publisher
  2. Besnard M, S xe9 razin C, Ossart J, Moreau A, Vimond N, Flippe L, et al. Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. J Clin Invest. 2022;132: pubmed publisher
  3. Oberhardt V, Luxenburger H, Kemming J, Schulien I, Ciminski K, Giese S, et al. Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature. 2021;597:268-273 pubmed publisher
  4. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed publisher
  5. Li N, Torres M, Spetz M, Wang R, Peng L, Tian M, et al. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. Cell Rep Med. 2021;2:100297 pubmed publisher
  6. Ercolano G, Gomez Cadena A, Dumauthioz N, Vanoni G, Kreutzfeldt M, Wyss T, et al. PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions. Nat Commun. 2021;12:2538 pubmed publisher
  7. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  8. Rosshirt N, Trauth R, Platzer H, Tripel E, Nees T, Lorenz H, et al. Proinflammatory T cell polarization is already present in patients with early knee osteoarthritis. Arthritis Res Ther. 2021;23:37 pubmed publisher
  9. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher
  10. Kasatskaya S, Ladell K, Egorov E, Miners K, Davydov A, Metsger M, et al. Functionally specialized human CD4+ T-cell subsets express physicochemically distinct TCRs. elife. 2020;9: pubmed publisher
  11. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed publisher
  12. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  13. Camu W, Mickunas M, Veyrune J, Payan C, Garlanda C, Locati M, et al. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine. 2020;59:102844 pubmed publisher
  14. Hanaoka H, Nishimoto T, Okazaki Y, Takeuchi T, Kuwana M. A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus. Arthritis Res Ther. 2020;22:88 pubmed publisher
  15. Martin E, Minet N, Boschat A, Sanquer S, Sobrino S, Lenoir C, et al. Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation. JCI Insight. 2020;5: pubmed publisher
  16. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  17. Gate D, Saligrama N, Leventhal O, Yang A, Unger M, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399-404 pubmed publisher
  18. Hurrell B, Galle Treger L, Jahani P, Howard E, Helou D, Banie H, et al. TNFR2 Signaling Enhances ILC2 Survival, Function, and Induction of Airway Hyperreactivity. Cell Rep. 2019;29:4509-4524.e5 pubmed publisher
  19. Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed publisher
  20. Pecher A, Kettemann F, Asteriti E, Schmid H, Duerr Stoerzer S, Keppeler H, et al. Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis. Arthritis Res Ther. 2019;21:212 pubmed publisher
  21. Zou F, Lu L, Liu J, Xia B, Zhang W, Hu Q, et al. Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56. Nat Commun. 2019;10:4109 pubmed publisher
  22. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed publisher
  23. Wang H, Shen L, Sun X, Liu F, Feng W, Jiang C, et al. Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity. Nat Commun. 2019;10:3254 pubmed publisher
  24. Banga R, Rebecchini C, Procopio F, Noto A, Munoz O, Ioannidou K, et al. Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement. PLoS Pathog. 2019;15:e1007918 pubmed publisher
  25. Fransen N, Crusius J, Smolders J, Mizee M, Van Eden C, Luchetti S, et al. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathol. 2020;30:106-119 pubmed publisher
  26. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  27. Ardain A, Domingo Gonzalez R, Das S, Kazer S, Howard N, Singh A, et al. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature. 2019;: pubmed publisher
  28. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed publisher
  29. de Jonge K, Ebering A, Nassiri S, Maby El Hajjami H, Ouertatani Sakouhi H, Baumgaertner P, et al. Circulating CD56bright NK cells inversely correlate with survival of melanoma patients. Sci Rep. 2019;9:4487 pubmed publisher
  30. Karimzadeh H, Kiraithe M, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze zur Wiesch J, et al. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level. Gastroenterology. 2019;156:1820-1833 pubmed publisher
  31. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed publisher
  32. Harper I, Gjorgjimajkoska O, Siu J, Parmar J, Mulder A, Claas F, et al. Prolongation of allograft survival by passenger donor regulatory T cells. Am J Transplant. 2019;19:1371-1379 pubmed publisher
  33. Williams P, Basu S, Garcia Manero G, Hourigan C, Oetjen K, Cortes J, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125:1470-1481 pubmed publisher
  34. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed publisher
  35. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  36. Wagner D, Amini L, Wendering D, Burkhardt L, Akyüz L, Reinke P, et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat Med. 2019;25:242-248 pubmed publisher
  37. Hoang T, Harper J, Pino M, Wang H, Micci L, King C, et al. Bone Marrow-Derived CD4+ T Cells Are Depleted in Simian Immunodeficiency Virus-Infected Macaques and Contribute to the Size of the Replication-Competent Reservoir. J Virol. 2019;93: pubmed publisher
  38. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  39. Inoue Y, Endo S, Matsuno N, Kikukawa Y, Shichijo T, Koga K, et al. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018;: pubmed publisher
  40. D Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, et al. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018;128:3490-3503 pubmed publisher
  41. Kim S, Knight D, Jones L, Vervoort S, Ng A, Seymour J, et al. JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias. Genes Dev. 2018;32:849-864 pubmed publisher
  42. Moalli F, Ficht X, Germann P, Vladymyrov M, Stolp B, de Vries I, et al. The Rho regulator Myosin IXb enables nonlymphoid tissue seeding of protective CD8+ T cells. J Exp Med. 2018;215:1869-1890 pubmed publisher
  43. Manickam C, Nwanze C, Ram D, Shah S, Smith S, Jones R, et al. Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract. AIDS. 2018;32:1571-1578 pubmed publisher
  44. Ondigo B, Ndombi E, Nicholson S, Oguso J, Carter J, Kittur N, et al. Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98:1770-1781 pubmed publisher
  45. Li N, van Unen V, Höllt T, Thompson A, van Bergen J, Pezzotti N, et al. Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. J Exp Med. 2018;215:1383-1396 pubmed publisher
  46. Seki A, Rutz S. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J Exp Med. 2018;215:985-997 pubmed publisher
  47. Zemmour D, Zilionis R, Kiner E, Klein A, Mathis D, Benoist C. Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR. Nat Immunol. 2018;19:291-301 pubmed publisher
  48. Jeffery H, McDowell P, Lutz P, Wawman R, Roberts S, Bagnall C, et al. Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. PLoS ONE. 2017;12:e0188649 pubmed publisher
  49. Maric J, Ravindran A, Mazzurana L, Björklund Ã, Van Acker A, Rao A, et al. Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol. 2018;141:1761-1773.e6 pubmed publisher
  50. Moreno Cubero E, Subira D, Sanz de Villalobos E, Parra Cid T, Madejon A, Miquel J, et al. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity. J Virol. 2018;92: pubmed publisher
  51. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed publisher
  52. Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M, et al. Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. Sci Rep. 2017;7:3501 pubmed publisher
  53. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  54. Kaczmarek D, Kokordelis P, Kramer B, Glässner A, Wolter F, Goeser F, et al. Alterations of the NK cell pool in HIV/HCV co-infection. PLoS ONE. 2017;12:e0174465 pubmed publisher
  55. Bittner S, Knoll G, Ehrenschwender M. Death receptor 3 signaling enhances proliferation of human regulatory T cells. FEBS Lett. 2017;591:1187-1195 pubmed publisher
  56. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed publisher
  57. Collins A, Rothman N, Liu K, Reiner S. Eomesodermin and T-bet mark developmentally distinct human natural killer cells. JCI Insight. 2017;2:e90063 pubmed publisher
  58. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  59. Wouters K, Gaens K, Bijnen M, Verboven K, Jocken J, Wetzels S, et al. Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue. Sci Rep. 2017;7:42665 pubmed publisher
  60. Hu Y, Lao L, Mao J, Jin W, Luo H, Charpentier T, et al. Armc5 deletion causes developmental defects and compromises T-cell immune responses. Nat Commun. 2017;8:13834 pubmed publisher
  61. Asano T, Meguri Y, Yoshioka T, Kishi Y, Iwamoto M, Nakamura M, et al. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 2017;129:2186-2197 pubmed publisher
  62. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed publisher
  63. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  64. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed publisher
  65. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  66. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  67. Klarquist J, Tobin K, Farhangi Oskuei P, Henning S, Fernandez M, Dellacecca E, et al. Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma. Cancer Res. 2016;76:6230-6240 pubmed
  68. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  69. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed publisher
  70. Gusscott S, Jenkins C, Lam S, Giambra V, Pollak M, Weng A. IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias. PLoS ONE. 2016;11:e0161158 pubmed publisher
  71. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed publisher
  72. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed publisher
  73. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  74. Brinkman C, Iwami D, Hritzo M, Xiong Y, Ahmad S, Simon T, et al. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration. Nat Commun. 2016;7:12021 pubmed publisher
  75. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed publisher
  76. Li W, Liu L, Gomez A, Zhang J, Ramadan A, Zhang Q, et al. Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease. JCI Insight. 2016;1: pubmed publisher
  77. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  78. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  79. Macdonald K, Hoeppli R, Huang Q, Gillies J, Luciani D, Orban P, et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J Clin Invest. 2016;126:1413-24 pubmed publisher
  80. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  81. Procaccini C, Carbone F, Di Silvestre D, Brambilla F, De Rosa V, Galgani M, et al. The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements. Immunity. 2016;44:406-21 pubmed publisher
  82. Trivedi P, Bruns T, Ward S, Mai M, Schmidt C, Hirschfield G, et al. Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity. J Autoimmun. 2016;68:98-104 pubmed publisher
  83. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  84. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed publisher
  85. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed publisher
  86. Laborel Préneron E, Bianchi P, Boralevi F, Lehours P, Fraysse F, Morice Picard F, et al. Effects of the Staphylococcus aureus and Staphylococcus epidermidis Secretomes Isolated from the Skin Microbiota of Atopic Children on CD4+ T Cell Activation. PLoS ONE. 2015;10:e0141067 pubmed publisher
  87. Heigele A, Joas S, Regensburger K, Kirchhoff F. Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels. Retrovirology. 2015;12:86 pubmed publisher
  88. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  89. Bézie S, Picarda E, Ossart J, Tesson L, Usal C, Renaudin K, et al. IL-34 is a Treg-specific cytokine and mediates transplant tolerance. J Clin Invest. 2015;125:3952-64 pubmed publisher
  90. Broos C, van Nimwegen M, Kleinjan A, Ten Berge B, Muskens F, In t Veen J, et al. Impaired survival of regulatory T cells in pulmonary sarcoidosis. Respir Res. 2015;16:108 pubmed publisher
  91. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed publisher
  92. Dunham J, Lee L, van Driel N, Laman J, Ni I, Zhai W, et al. Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol. 2016;11:73-83 pubmed publisher
  93. James J, Hurley D, Gamage T, Zhang T, Vather R, Pantham P, et al. Isolation and characterisation of a novel trophoblast side-population from first trimester placentae. Reproduction. 2015;150:449-62 pubmed publisher
  94. Klippert A, Stolte Leeb N, Neumann B, Sauermann U, Daskalaki M, Gawanbacht A, et al. Frequencies of lymphoid T-follicular helper cells obtained longitudinally by lymph node fine-needle aspiration correlate significantly with viral load in SIV-infected rhesus monkeys. J Med Primatol. 2015;44:253-62 pubmed publisher
  95. Hanley P, Melenhorst J, Nikiforow S, Scheinberg P, Blaney J, Demmler Harrison G, et al. CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo. Sci Transl Med. 2015;7:285ra63 pubmed publisher
  96. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed publisher
  97. Schmueck Henneresse M, Sharaf R, Vogt K, Weist B, Landwehr Kenzel S, Fuehrer H, et al. Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency. J Immunol. 2015;194:5559-67 pubmed publisher
  98. Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015;50:924-30 pubmed publisher
  99. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  100. Rochman Y, Yukawa M, Kartashov A, Barski A. Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig. PLoS ONE. 2015;10:e0122198 pubmed publisher
  101. Axelsson Robertson R, Ju J, Kim H, Zumla A, Maeurer M. Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis. Int J Infect Dis. 2015;32:13-22 pubmed publisher
  102. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  103. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  104. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed publisher
  105. Okamura T, Sumitomo S, Morita K, Iwasaki Y, Inoue M, Nakachi S, et al. TGF-β3-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. Nat Commun. 2015;6:6329 pubmed publisher
  106. Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson M, Kekäläinen E, et al. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol. 2015;194:2467-71 pubmed publisher
  107. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  108. Laranjeira P, Pedrosa M, Pedreiro S, Gomes J, Martinho A, Antunes B, et al. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells. Stem Cell Res Ther. 2015;6:3 pubmed publisher
  109. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed publisher
  110. Rueda C, Wells C, Gisslen T, Jobe A, Kallapur S, Chougnet C. Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates. Hum Immunol. 2015;76:65-73 pubmed publisher
  111. Huss D, Mehta D, Sharma A, You X, Riester K, Sheridan J, et al. In vivo maintenance of human regulatory T cells during CD25 blockade. J Immunol. 2015;194:84-92 pubmed
  112. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  113. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed publisher
  114. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed publisher
  115. van der Waart A, van de Weem N, Maas F, Kramer C, Kester M, Falkenburg J, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 2014;124:3490-500 pubmed publisher
  116. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher
  117. Kurktschiev P, Raziorrouh B, Schraut W, Backmund M, Wächtler M, Wendtner C, et al. Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction. J Exp Med. 2014;211:2047-59 pubmed publisher
  118. Bending D, Pesenacker A, Ursu S, Wu Q, Lom H, Thirugnanabalan B, et al. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis. J Immunol. 2014;193:2699-708 pubmed publisher
  119. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed publisher
  120. Herrera A, Kim H, Bindra B, Jones K, Alyea E, Armand P, et al. A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20:1737-43 pubmed publisher
  121. Noyan F, Lee Y, Zimmermann K, Hardtke Wolenski M, Taubert R, Warnecke G, et al. Isolation of human antigen-specific regulatory T cells with high suppressive function. Eur J Immunol. 2014;44:2592-602 pubmed publisher
  122. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  123. Breuer J, Schwab N, Schneider Hohendorf T, Marziniak M, Mohan H, Bhatia U, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75:739-58 pubmed publisher
  124. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed publisher
  125. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  126. Peguillet I, Milder M, Louis D, Vincent Salomon A, Dorval T, Piperno Neumann S, et al. High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res. 2014;74:2204-16 pubmed publisher
  127. Galindo Albarrán A, Ramirez Pliego O, Labastida Conde R, Melchy Pérez E, Liquitaya Montiel A, Esquivel Guadarrama F, et al. CD43 signals prepare human T cells to receive cytokine differentiation signals. J Cell Physiol. 2014;229:172-80 pubmed
  128. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed publisher
  129. Nikiforow S, Kim H, Bindra B, McDonough S, Glotzbecker B, Armand P, et al. Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2013;19:804-11 pubmed publisher
  130. Koreth J, Stevenson K, Kim H, McDonough S, Bindra B, Armand P, et al. Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation. J Clin Oncol. 2012;30:3202-8 pubmed publisher
  131. Koreth J, Matsuoka K, Kim H, McDonough S, Bindra B, Alyea E, et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med. 2011;365:2055-66 pubmed publisher
  132. Randall K, Chan S, Ma C, Fung I, Mei Y, Yabas M, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208:2305-20 pubmed publisher